CL2012000462A1 -
Oxazine derived compounds, bace inhibitors; pharmaceutical composition comprising them; Useful in the treatment of Alzheimer's.
- Google Patents
Oxazine derived compounds, bace inhibitors; pharmaceutical composition comprising them; Useful in the treatment of Alzheimer's.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of CL2012000462A1publicationCriticalpatent/CL2012000462A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
SE DAN A CONOCER DERIVADOS DE OXAZINA SELECCIONADOS A PARTIR DEL GRUPO QUE CONSISTE DE: LOS CUALES TIENEN UNA ACTIVIDAD INHIBIDORA DE BACE, EN FORMA LIBRE O EN FORMA DE SAL, Y UNA COMPOSICION FARMACEUTICA QUE LOS CONTIENE.SELECTED OXAZINE DERIVATIVES ARE DISCLOSED FROM THE GROUP THAT CONSISTS OF: WHICH HAVE A BACE INHIBITOR ACTIVITY, IN FREE OR IN THE FORM OF SALT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM.
CL2012000462A2010-01-122012-02-23
Oxazine derived compounds, bace inhibitors; pharmaceutical composition comprising them; Useful in the treatment of Alzheimer's.
CL2012000462A1
(en)
Compounds derived from benzyl sulfonamide, mogat-2 inhibitors; crystalline compound; pharmaceutical composition; and its use in the treatment of hypertriglyceridemia.